South Wales, Aug. 21 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "MELZONIX" on Aug. 7. The details about the trademark application no. UK00004427697 published in the journal no. 2026/034 (Aug. 21).
With Appleyard Lees IP LLP as representative, Regeneron Pharmaceuticals, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy; Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004427697
Disclaimer: Curated by HT Syndication.
